KER-050

A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Arms / Cohorts

Experimental:KER-050 Cohort 1

Accepting patients

Experimental:KER-050 Cohort 2

Accepting patients

Experimental:KER-050 Cohort 3

Accepting patients

Experimental:KER-050 Cohort 4

Accepting patients

Experimental:KER-050 Cohort 5

Accepting patients

Experimental:KER-050 Dose Confirmation Cohort

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.